CHANDLER REGIONAL MEDICAL CENTER
1. Target Overview & Investment Thesis
CHANDLER REGIONAL MEDICAL CENTER is a 429-bed suburban community hospital in MARICOPA, AZ with $700.3M in net patient revenue and a -2.0% operating margin. The hospital serves a payer mix of 22.0% Medicare, 16.9% Medicaid, and 61.1% commercial.
Thesis: Undervalued. Our ML models identify $51.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -2.0% to 5.4% (+736bps).
| Net Revenue HCRIS | $700.3M |
| Current EBITDA COMPUTED | $-14.0M |
| Operating Margin COMPUTED | -2.0% |
| Occupancy HCRIS | 84.1% |
| Revenue / Bed COMPUTED | $1.6M |
| Net-to-Gross HCRIS | 16.1% |
| Distress Probability ML | 42.2% |
2. Market Context & Competitive Position
AZ has 124 Medicare-certified hospitals with a median operating margin of -0.8%. The target's margin of -2.0% places it below the state median. Among 23 size-comparable peers (214-858 beds), the median margin is -1.0%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (214-858), prioritizing same-state peers. 23 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CHANDLER REGIONAL MEDICAL CENT (Target) | AZ | 429 | $700.3M | -2.0% |
| MAYO CLINIC HOSPITAL | AZ | 315 | $2.25B | 1.4% |
| BANNER ESTRELLA MEDICAL CENTER | AZ | 317 | $1.84B | 79.2% |
| BANNER BAYWOOD MEDICAL CENTER | AZ | 323 | $1.39B | 79.1% |
| ST. JOSEPHS HOSPITAL & MEDICAL | AZ | 515 | $1.31B | -17.7% |
| PHOENIX CHILDRENS HOSPITAL | AZ | 352 | $1.26B | 6.0% |
| BANNER UNIVERSITY MEDICAL CENT | AZ | 656 | $1.09B | -5.9% |
| BANNER UNIVERSITY MED CENTER T | AZ | 533 | $1.03B | -4.6% |
| BANNER DESERT MEDICAL CENTER | AZ | 629 | $833.1M | 12.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $51.5M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $14.7M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $14.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $13.9M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $8.5M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $448K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-14.0M |
| + RCM Uplift | +$51.5M |
| Pro Forma EBITDA | $37.5M |
| Current Margin | -2.0% |
| Pro Forma Margin | 5.4% |
| WC Released (1x) | $26.9M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-21.6M | $422.8M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-21.6M | $458.1M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-19.4M | $621.2M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-19.4M | $671.9M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-23.8M | $172.1M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-23.8M | $181.6M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Low | Low net-to-gross ratio | Large contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 23 hospitals with 214-858 beds
- Same-state prioritization (n=24)
- Comp margins: P25=-5.2% / P50=-1.0% / P75=6.2%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.